Importantly, ASAP2 knockdown weakened the responsiveness of HCC cells towards HGF stimulation, as evidenced by greatly reduced levels of phosphorylated c-MET, AKT, and ERK1/2 in ASAP2-knockdown cells after HGF treatment (Fig. 6C). The gene discussed is MET; the disease is hepatocellular carcinoma.